FuelCell Energy Inc vs Liquidia Corporation Common Stock — how do they compare? FuelCell Energy Inc trades at $13.96 (market cap $1.24B), while Liquidia Corporation Common Stock trades at $33.49 (market cap $2.40B). The key difference: Liquidia Corporation Common Stock is the larger of the two by market cap, and FuelCell Energy Inc is more actively traded (7,483,477 versus 2,857,547). Which is the better fit depends on your goals — on Pluang, investors hold FuelCell Energy Inc for 48 Days and Liquidia Corporation Common Stock for 0 Days on average.
| FCEL | LQDA | |
|---|---|---|
Market Cap | $1.24B | $2.40B |
Volume | 7,483,477 | 2,857,547 |
Sector | Industrials | Health |
52-Week High | $36.01 | $91.03 |
52-Week Low | $6.00 | $22.02 |
Typical Hold Time | 48 Days | 0 Days |
Enterprise Value | $818.79M | $2.30B |
Signals from Pluang's Aura AI — not financial advice
FuelCell Energy (FCEL) trades at $14.16, down 13.5% over 24 hours, reflecting negative momentum amid ongoing operational losses. The stock exhibits a bearish technical signal, with key support at $14. Recent financials show revenue of $158.16M in 2025 but a net loss of $187.90M, with negative gross and net income margins. Analyst consensus is split evenly between Buy and Hold, with a $21.57 price target. Multiple law firms have announced securities class actions related to disclosures from June to September 2026, adding legal overhangs.
FCEL's outlook remains challenged by persistent unprofitability and cash burn, though analyst targets suggest potential upside from current levels. Key risks include the class action lawsuits, execution on scaling power agreements, and the company's ability to achieve positive cash flow. The stock presents a high-risk opportunity contingent on operational turnaround and resolution of legal issues.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →